Open AccessUsing Fludarabine to Reduce Exposure to Alkylating Agents in Children with Sickle Cell Disease Receiving Busulfan, Cyclophosphamide, and Antithymocyte Globulin Transplant Conditioning: Results of a Dose De-Escalation Trial
Author(s) -
John Horan,
Ann E. Haight,
Jacqueline Lagerlof Dioguardi,
Clark Brown,
Audrey Grizzle,
Chiani Shelman,
Julie Kanter,
G Hale,
Michael L. Nieder,
Melody Benton,
Kimberly A. Kasow,
Allistair Abraham,
KuangYueh Chiang
Publication year - 2015
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/n7yz-zw38
Subject(s) - busulfan , fludarabine , cyclophosphamide , medicine , disease , oncology , chemotherapy